01929

10.9202.06%
CC

Chi-Heng Cheng

Executive Vice-Chairman of the Board

Mr. Chi-Heng Cheng, also known as Conroy, has been an Executive Director of Chow Tai Fook Jewellery Group Limited since July 26, 2011 and serves as its Executive Vice Chairman of the Board since June 09, 2022. He serves as a Director of Advance Pharmaceutical Company. He serves as a Director of Chow Tai Fook Enterprises Limited and Chow Tai Fook (Holding) Limited. He had been an Executive Director for New World Development Company Limited since June 1, 2010 until December 01, 2022 and serves as its Non-Executive Director since December 01, 2022. He had been the Chief Executive Officer and Chief Financial Officer of Boston Therapeutics, Inc. since December 13, 2019 until June 04, 2021 and had been its Director since December 4, 2013 until June 04, 2021. Mr. Cheng served as the Interim Chief Executive Officer and Interim Chief Financial Officer of Boston Therapeutics, Inc. from March 16, 2016 to August 12, 2016. He serves as the Chief Executive Officer of Net Plus Company Limited. Mr. Cheng served as Company Secretary at Boston Therapeutics, Inc. until June 04, 2021. Mr. Cheng served as Corporate Finance Executive at Yu Ming Investment Management Limited from 1999 to 2000. He serves as an Executive Director of Net Plus Company Limited. He served as Non-Executive Director of China Huishan Dairy Holdings Company Limited until June 23, 2015. He served as an Independent Non-Executive Director of Hong Kong Energy Holdings Limited (alternate name JIC Technology Co. Ltd. & China Renewable Energy Investment Limited) from July 2, 2002 to May 11, 2007. He served as a Director of Alpharx Inc. since April 2010. He received a Bachelor of Arts degree majoring in Economics from the University of Western Ontario, Ontario, Canada in 1999.

Positions